Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses

Journal of Autoimmunity - Tập 124 - Trang 102715 - 2021
Saathvik R. Kannan1, Austin N. Spratt1, Alisha R. Cohen1, S. Hasan Naqvi2, Hitendra S. Chand3, Thomas P. Quinn4, Christian L. Lorson5, Siddappa N. Byrareddy6,7, Kamal Singh1,5,7,8
1Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA
2Department of Medicine, University of Missouri, Columbia, MO 65211, USA
3Department of Immunology and Nanomedicine, Florida International University, Miami, FL, USA
4Department of Biochemistry University of Missouri, Columbia, MO 65211 USA
5Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA
6Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68131, USA
7Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
8Sanctum Therapeutics Corporation, Sunnyvale, CA, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

SARS-CoV-2 variant classifications and definitions. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html (July 16, 2021).

Domingo, 1997, RNA virus mutations and fitness for survival, Annu. Rev. Microbiol., 51, 151, 10.1146/annurev.micro.51.1.151

J. A. Plante, Y. Liu, J. Liu, H. Xia, B. A. Johnson, K. G. Lokugamage, X. Zhang, A. E. Muruato, A J. Zou, C. R. Fontes-Garfias, D. Mirchandani, D. Scharton, J. P. Bilello, Z. Ku, Z. An, B. Kalveram, A. N. Freiberg, V. D. Menachery, X. Xie, K. S. Plante, S. C. Weaver P. Y. Shi, Spike mutation D614G alters SARS-CoV-2 fitness. Nature 592 (2021):116-121.

Baric, 2020, Emergence of a highly fit SARS-CoV-2 variant, N. Engl. J. Med., 383, 2684, 10.1056/NEJMcibr2032888

Elbe, 2017, Data, disease and diplomacy: GISAID's innovative contribution to global health, Glob. Chall., 1, 33, 10.1002/gch2.1018

Korber, 2020, Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus, Cell, 182, 812, 10.1016/j.cell.2020.06.043

Kannan, 2020, Infectivity of SARS-CoV-2: there is something more than D614G?, J. Neuroimmune Pharmacol., 15, 574, 10.1007/s11481-020-09954-3

Spratt, 2021, Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants, Comput. Struct. Biotechnol. J., 19, 3799, 10.1016/j.csbj.2021.06.037

Liu, 2021, Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum, Cell, 184, 1, 10.1016/j.cell.2021.06.020

Berman, 2000, The protein Data Bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235

Cerutti, 2021, Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite, Cell Host Microbe, 29, 819, 10.1016/j.chom.2021.03.005

Barnes, 2020, Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies, Cell, 182, 828, 10.1016/j.cell.2020.06.025

Campbell, 2021, Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021, Euro Surveill., 26, 2100509, 10.2807/1560-7917.ES.2021.26.24.2100509

Scudellari, 2021, How the coronavirus infects cells - and why delta is so dangerous, Nature, 595, 640, 10.1038/d41586-021-02039-y

Hadfield, 2018, Real-time tracking of pathogen evolution, Bioinformatics, 34, 4121, 10.1093/bioinformatics/bty407